- Home
- IMVT vs FULT Comparison
IMVT vs FULT Comparison
Compare IMVT & FULT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMVT
- FULT
- Stock Information
- Founded
- IMVT N/A
- FULT 1882
- Country
- IMVT United States
- FULT United States
- Employees
- IMVT N/A
- FULT N/A
- Industry
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- FULT Major Banks
- Sector
- IMVT Health Care
- FULT Finance
- Exchange
- IMVT Nasdaq
- FULT Nasdaq
- Market Cap
- IMVT 3.4B
- FULT 3.6B
- IPO Year
- IMVT N/A
- FULT N/A
- Fundamental
- Price
- IMVT $18.37
- FULT $17.97
- Analyst Decision
- IMVT Strong Buy
- FULT Hold
- Analyst Count
- IMVT 11
- FULT 5
- Target Price
- IMVT $44.13
- FULT $20.20
- AVG Volume (30 Days)
- IMVT 1.9M
- FULT 1.3M
- Earning Date
- IMVT 02-06-2025
- FULT 04-15-2025
- Dividend Yield
- IMVT N/A
- FULT 4.01%
- EPS Growth
- IMVT N/A
- FULT N/A
- EPS
- IMVT N/A
- FULT 1.57
- Revenue
- IMVT N/A
- FULT $1,147,690,000.00
- Revenue This Year
- IMVT $108.88
- FULT N/A
- Revenue Next Year
- IMVT N/A
- FULT $5.26
- P/E Ratio
- IMVT N/A
- FULT $11.43
- Revenue Growth
- IMVT N/A
- FULT 11.65
- 52 Week Low
- IMVT $17.01
- FULT $13.87
- 52 Week High
- IMVT $34.47
- FULT $22.49
- Technical
- Relative Strength Index (RSI)
- IMVT 42.05
- FULT 39.40
- Support Level
- IMVT $17.49
- FULT $17.87
- Resistance Level
- IMVT $18.96
- FULT $18.64
- Average True Range (ATR)
- IMVT 1.23
- FULT 0.40
- MACD
- IMVT -0.01
- FULT 0.08
- Stochastic Oscillator
- IMVT 39.65
- FULT 55.33
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage biopharmaceutical company. It is focused on enabling normal lives for patients with autoimmune diseases. The company's product includes batoclimab and IMVT-1402 targets the neonatal Fc receptor (FcRn).
About FULT Fulton Financial Corporation
Fulton Financial is a U.S.-based financial services holding company that operates in five states: Pennsylvania, Delaware, Maryland, New Jersey, and Virginia. It offers a range of consumer and commercial banking products and services, such as checking and savings deposit products and loan products. It offers consumer and commercial banking products and services, as well as wealth management products and services. The bank derives its revenue from non-interest income, led by its Wealth Management division.